Howard Sklamberg’s promotion continues FDA’s pattern of taking compliance directors to head its globalization-focused directorate.
Sklamberg, now director of the Center for Drug Evaluation and Research’s Office of Compliance, will take over as deputy commissioner...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?